Malignant Brain Tumors
Malignant brain tumors contain cancer cells and often have no clear borders. Unlike benign tumors, the malignant brain tumor cell structure is very different than that of normal brain cells. Malignant tumors tend to grow faster and be more invasive than benign tumors and are thus life-threatening. Sometimes malignant brain tumors are also called brain cancer, although they do not share all of same the characteristics of cancer. Cancer is most notably characterized by the ability to spread from one organ to another. It’s extremely rare for primary brain tumors to spread beyond the brain or spine.
Tumors are classified from Grade I through Grade IV. The higher the grade, the more aggressive and dangerous the tumor. Staging is another way to describe a tumor and how widely it has spread. Staging for central nervous system tumors is typically assessed by using imaging techniques like CT and MRI scans or by examining the cerebrospinal fluid.
Over 120 types of brain and central nervous system tumors have been identified. Classifying, grading and staging these tumors help physicians and other medical professionals communicate more clearly about the tumor. It also helps them to better understand the patient's current health, prognosis and the best treatment recommendations.
Malignant Brain Tumor Symptoms
The symptoms of brain tumors are:
- Changes in mood, personality, or ability to concentrate
- Changes in speech, vision, or hearing
- Muscle jerking or twitching (convulsions and/or seizures)
- Nausea and vomiting
- Numbness or tingling in the arms or legs
- Problems balancing or walking
- Problems with memory
Our team of specialists provides the most up-to-date evaluations using the latest diagnostic and imaging technology.
We work very closely with the departments of Neurosurgery, Interventional Neuroradiology, Neurology and Radiation Oncology, as well as the Normal Pressure Hydrocephalus Center and Skull Base Center to ensure an accurate diagnosis and the appropriate treatment for the best outcome.